Date published:
Audience:
General public
Two projects will share $5.5 million from Stream 2 of the 2021 Rare Cancers, Rare Diseases and Unmet Need grant opportunity under the MRFF’s Clinical Trials Activity initiative.
Researchers will:
- evaluate new therapies for women with breast cancer under 45 years of age
- test a new therapy for treatment resistant triple-negative breast cancer.
Read the media release for more information.
Learn about the MRFF.